Literature DB >> 2782464

Physiological role of HMG-CoA reductase in regulating egg production by Schistosoma mansoni.

E A Vandewaa1, G Mills, G Z Chen, L A Foster, J L Bennett.   

Abstract

Pathological lesions observed in humans infected with Schistosoma mansoni are due to the eggs produced by the female parasite. Mevinolin, a potent inhibitor of the enzyme hydroxymethylglutaryl-CoA (HMG-CoA) reductase, blocks egg production by this parasite. In this report, we demonstrate that cholesterol precursors, mevalonate and farnesol, stimulate egg production by the female parasite and that these precursors can reverse the mevinolin-induced inhibition of egg production. Because the parasite cannot synthesize cholesterol, we incubated parasites in a culture media containing radiolabeled acetate with and without mevinolin. We isolated nonsterol lipids from the parasite and observed that mevinolin dramatically reduced the conversion of acetate into the polyisoprenoid (dolichols) lipids of the parasite. Dolichols and other nonsterol lipids did not stimulate egg production. HMG-CoA reductase activity was observed in homogenates of the parasite and was inhibited by mevinolin (Ki = 52 nM), but its activity was tripled when the parasite was chronically exposed to low doses of the drug. Parasites with increased reductase activity produced five to six times more eggs. Lastly, chronic administration of large doses of mevinolin to infected mice resulted in a marked reduction of the pathology associated with the infection. These results suggest that egg production in S. mansoni is associated with the parasite's HMG-CoA reductase activity and that a nonsterol lipid produced in the biochemical pathway regulated by this enzyme stimulates egg production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782464     DOI: 10.1152/ajpregu.1989.257.3.R618

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Phenantroline, lovastatin, and mebendazole do not inhibit oviposition in the murine experimental infection with Angiostrongylus costaricensis.

Authors:  Márcia Bohrer Mentz; Eliane Dallegrave; Aventino Agostini; Carlos Graeff-Teixeira
Journal:  Parasitol Res       Date:  2006-08-30       Impact factor: 2.289

2.  Protein interactions with a gender-specific gene of Schistosoma mansoni: characterization by DNase I footprinting, band shift and UV cross-linking.

Authors:  S Engelender; A L Giannini; F D Rumjanek
Journal:  Mol Cell Biochem       Date:  1993-07-21       Impact factor: 3.396

3.  Antischistosomal action of mevinolin: evidence that 3-hydroxy-methylglutaryl-coenzyme a reductase activity in Schistosoma mansoni is vital for parasite survival.

Authors:  G Z Chen; L Foster; J L Bennett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

4.  Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.

Authors:  A S Couto; E A Kimura; V J Peres; M L Uhrig; A M Katzin
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

5.  Specific binding of human low-density lipoprotein to the surface of schistosomula of Schistosoma mansoni and ingestion by the parasite.

Authors:  M W Bennett; J P Caulfield
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

6.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Identification of attractive drug targets in neglected-disease pathogens using an in silico approach.

Authors:  Gregory J Crowther; Dhanasekaran Shanmugam; Santiago J Carmona; Maria A Doyle; Christiane Hertz-Fowler; Matthew Berriman; Solomon Nwaka; Stuart A Ralph; David S Roos; Wesley C Van Voorhis; Fernán Agüero
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

8.  In Silico Models for Ecotoxicity of Pharmaceuticals.

Authors:  Kunal Roy; Supratik Kar
Journal:  Methods Mol Biol       Date:  2016

9.  Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.

Authors:  Fernanda C Cardoso; Gilson C Macedo; Elisandra Gava; Gregory T Kitten; Vitor L Mati; Alan L de Melo; Marcelo V Caliari; Giulliana T Almeida; Thiago M Venancio; Sergio Verjovski-Almeida; Sergio C Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01

10.  Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions.

Authors:  Thiago M Venancio; Ricardo DeMarco; Giulliana T Almeida; Katia C Oliveira; João C Setubal; Sergio Verjovski-Almeida
Journal:  BMC Genomics       Date:  2007-11-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.